21 February 2018
News and Views
Links and Services
June's Alimentary Pharmacology & Therapeutics assessed long-term safety of proton pump inhibitor therapy.
Control of chronic gastro-esophageal reflux disease may be achieved either by anti-reflux surgery
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors